Elon Musk’s Neelink Brain Fin Fin is equipped with 2 quadriplegic patients Canadian as part of a clinical trial
Two Canadian patients with the spinal cord injuries have discovered the neaburak’s brain plants that allow them to control the computer with their thoughts.
They are part of the first clinical trial without a test of the safety of the safety and efficiency of Elon Musk’s Nealible Wireless Wireless Chip, informing the public in 2020, and started to be included in an American community disabled in 2024.
The Canadian men, aged about 30 years old – one from Ontario, one from Alberta – is limited or no power to use their hands.
Dr Andres Lozano, neurosurgeon at the University of Health Leaded a Western Hospital, said patients could move a computer cursor immediately after surgery. Both were able to leave the hospital in the morning after their processes in Aug. 27 And September 3, he said.
The electrodes are included in the mental mental area that work with neuron signals and translate those signs in external acts, violating the need for physical movement, Lobano explained.
“The first patient was able to control the cursor by thinking within minutes. Too fast.
“They just think about it and happen.”
What is expecting expectations
Brain-computer interface (BCI) do not store up to neuralks, and other companies such as New-York Sychchron, conducting their clinic exams.
The promise of this technology is encouraging, but expected should be angry, Barry Munro said, the Chief Executive Officer of the Canadian Research State.
Munri, who has been quadriplegic from the accident 38 years ago, said he gave his life to the spinal cord, and helped to hire the trial of NE-ANDAURALINK.
The first person to find the device last year and talked about the public that he started the churches in the churches after his brain after surgery, but he was making progress, and that it was achieved.
Munro says he has seen the “false hope” and in the field and rather promotes “Hope Unducted” – Learning and Rejoicing without Expecting the following six months.
“We are not yet now, that’s all,” he said.
The first patient of people received the installation from neuralk, at the computer-brain interface company. Andrew Chang tests the hardness of N1 LeFant, how it works in clinical trials, and that neuralk is trying to achieve the device.
Clinical case examines safety, quality of life
The Canadian patients will be considered at least a year, a clinical research team is allowed to register four other patients in a country threatened by spine or amyatroph sclerosis (ALS).
The clinic team will be analyzed if technology is safe and if adding the quality of the patient’s health. The bad effects they will want can include constipation, disease or stripes.
In the next weeks and months, patients will learn to type in computer without touching the keyboard. Of course, they are able to play video games.
“Really as a first step to see if this should be extracted and released from many people,” Lizano
He said.
“The device is currently a directions, but next time you can drive a car, you can drive your wheelchair, you can call a robot.”
